| Prof Vikramaditya Dulam, MD | |
|
140 Jefferson Davis Blvd, Natchez, MS 39120-5104 | |
| (601) 304-9718 | |
| (601) 304-9637 |
| Full Name | Prof Vikramaditya Dulam |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 32 Years |
| Location | 140 Jefferson Davis Blvd, Natchez, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194767806 | NPI | - | NPPES |
| 02602371 | Medicaid | MS | |
| 1197785 | Other | LOUISIANA MEDICAID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 18344 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Riverland Medical Center | Ferriday, LA | Hospital |
| Merit Health Natchez | Natchez, MS | Hospital |
| Merit Health River Region | Vicksburg, MS | Hospital |
| Entity Name | Concordia Parish Hospital Service District Number One |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952565335 PECOS PAC ID: 4587559935 Enrollment ID: O20041012000111 |
News Archive
A new study presented today at EULAR 2013, the Annual Congress of the European League Against Rheumatism, shows that overweight and obese patients are less likely to achieve successful remission in early rheumatoid arthritis compared to those of normal weight.
The first clinical study of a low-cost neonatal breathing system created by Rice University bioengineering students demonstrated that the device increased the survival rate of newborns with severe respiratory illness from 44 percent to 71 percent.
UPM researchers are involved in the development of a new biosensor that can be useful to achieve an early non-invasive diagnosis of Alzheimer's disease using magnetic resonance imaging.
University of Cincinnati (UC) researchers have discovered a biomarker, known as phosphatidylserine (PS), for pancreatic cancer that could be effectively targeted, creating a potential therapy for a condition that has a small survival rate.
› Verified 9 days ago
| Entity Name | Miss Lou Health Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598707150 PECOS PAC ID: 4880696897 Enrollment ID: O20091109000015 |
News Archive
A new study presented today at EULAR 2013, the Annual Congress of the European League Against Rheumatism, shows that overweight and obese patients are less likely to achieve successful remission in early rheumatoid arthritis compared to those of normal weight.
The first clinical study of a low-cost neonatal breathing system created by Rice University bioengineering students demonstrated that the device increased the survival rate of newborns with severe respiratory illness from 44 percent to 71 percent.
UPM researchers are involved in the development of a new biosensor that can be useful to achieve an early non-invasive diagnosis of Alzheimer's disease using magnetic resonance imaging.
University of Cincinnati (UC) researchers have discovered a biomarker, known as phosphatidylserine (PS), for pancreatic cancer that could be effectively targeted, creating a potential therapy for a condition that has a small survival rate.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Prof Vikramaditya Dulam, MD 140 Jefferson Davis Blvd, Natchez, MS 39120-5104 Ph: (601) 304-9718 | Prof Vikramaditya Dulam, MD 140 Jefferson Davis Blvd, Natchez, MS 39120-5104 Ph: (601) 304-9718 |
News Archive
A new study presented today at EULAR 2013, the Annual Congress of the European League Against Rheumatism, shows that overweight and obese patients are less likely to achieve successful remission in early rheumatoid arthritis compared to those of normal weight.
The first clinical study of a low-cost neonatal breathing system created by Rice University bioengineering students demonstrated that the device increased the survival rate of newborns with severe respiratory illness from 44 percent to 71 percent.
UPM researchers are involved in the development of a new biosensor that can be useful to achieve an early non-invasive diagnosis of Alzheimer's disease using magnetic resonance imaging.
University of Cincinnati (UC) researchers have discovered a biomarker, known as phosphatidylserine (PS), for pancreatic cancer that could be effectively targeted, creating a potential therapy for a condition that has a small survival rate.
› Verified 9 days ago
Dr. Alphonse Michael Reed, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 55 Sgt Prentiss Dr, Suite 102, Natchez, MS 39120 Phone: 601-445-7352 Fax: 601-445-7353 | |
Dr. Kenneth Sloan Drane, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 329 Highland Blvd, Natchez, MS 39120 Phone: 601-445-0740 Fax: 601-897-4210 | |
Jennifer L. Hebert, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 46 Sergeant Prentiss Dr Ste 201, Natchez, MS 39120 Phone: 601-445-1715 Fax: 601-445-6720 | |
Jack Joseph Rodriguez, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 106 Jefferson Davis Blvd, Suite 120, Natchez, MS 39120 Phone: 601-442-9210 Fax: 601-442-7409 | |
Dr. Akinremi Ayodeji Akinwale, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 129 Jefferson Davis Blvd., Natchez, MS 39120 Phone: 601-445-1736 Fax: 601-446-1753 | |
Dr. Thomas Bradford Lemay, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 46 Sgt Prentiss Dr, Suite 204, Natchez Regional Medical Office Building, Natchez, MS 39120 Phone: 601-653-4927 Fax: 601-897-0542 |